Cargando…
A Review of the Pathophysiology and Novel Treatments for Erectile Dysfunction
Erectile dysfunction (ED) affects up to 50% of men between the ages of 40 and 70. Treatment with PDE-5 inhibitors is effective in the majority of men with ED. However, PDE-5 inhibitors are not effective when levels of nitric oxide (NO), the principle mediator of erection, are low. The pharmacologic...
Autores principales: | Lasker, George F., Maley, Jason H., Kadowitz, Philip J. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2997760/ https://www.ncbi.nlm.nih.gov/pubmed/21152267 http://dx.doi.org/10.1155/2010/730861 |
Ejemplares similares
-
Pathophysiology of visual disorders induced by phosphodiesterase inhibitors in the treatment of erectile dysfunction
por: Moschos, Marilita M, et al.
Publicado: (2016) -
Understanding the cellular basis and pathophysiology of Peyronie’s disease to optimize treatment for erectile dysfunction
por: Campbell, Jeffrey, et al.
Publicado: (2017) -
Tadalafil in the treatment of erectile dysfunction
por: Coward, Robert M, et al.
Publicado: (2008) -
Udenafil for the treatment of erectile dysfunction
por: Cho, Min Chul, et al.
Publicado: (2014) -
Novel Emerging Therapies for Erectile Dysfunction
por: Kim, Soyeun, et al.
Publicado: (2021)